NBC Securities Inc. Has $51,000 Stock Holdings in Baxter International Inc. (NYSE:BAX)

NBC Securities Inc. lowered its stake in shares of Baxter International Inc. (NYSE:BAX) by 18.2% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,349 shares of the medical instruments supplier’s stock after selling 300 shares during the period. NBC Securities Inc.’s holdings in Baxter International were worth $51,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the stock. Valeo Financial Advisors LLC bought a new stake in Baxter International in the third quarter worth approximately $218,000. Livforsakringsbolaget Skandia Omsesidigt boosted its position in Baxter International by 229.9% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 4,747 shares of the medical instruments supplier’s stock worth $180,000 after purchasing an additional 3,308 shares during the period. First PREMIER Bank acquired a new position in Baxter International during the third quarter valued at approximately $25,000. GAMMA Investing LLC lifted its stake in shares of Baxter International by 6.5% in the third quarter. GAMMA Investing LLC now owns 7,517 shares of the medical instruments supplier’s stock worth $285,000 after buying an additional 459 shares during the last quarter. Finally, Handelsbanken Fonder AB boosted its holdings in shares of Baxter International by 8.7% during the 3rd quarter. Handelsbanken Fonder AB now owns 217,629 shares of the medical instruments supplier’s stock worth $8,263,000 after buying an additional 17,450 shares during the period. 90.19% of the stock is currently owned by hedge funds and other institutional investors.

Baxter International Trading Up 0.6 %

Shares of BAX stock opened at $36.86 on Monday. The firm has a fifty day moving average of $37.61 and a 200-day moving average of $36.58. The stock has a market cap of $18.78 billion, a price-to-earnings ratio of 7.09, a P/E/G ratio of 1.28 and a beta of 0.59. Baxter International Inc. has a 52-week low of $31.70 and a 52-week high of $44.01. The company has a debt-to-equity ratio of 1.35, a quick ratio of 0.91 and a current ratio of 1.40.

Baxter International (NYSE:BAX) last posted its quarterly earnings results on Tuesday, August 6th. The medical instruments supplier reported $0.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.66 by $0.02. The firm had revenue of $3.81 billion during the quarter, compared to analyst estimates of $3.75 billion. Baxter International had a net margin of 16.51% and a return on equity of 18.06%. The company’s quarterly revenue was up 2.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.55 earnings per share. On average, equities research analysts forecast that Baxter International Inc. will post 2.96 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. The Goldman Sachs Group boosted their target price on shares of Baxter International from $36.00 to $40.00 and gave the stock a “neutral” rating in a research report on Thursday, August 8th. StockNews.com cut Baxter International from a “buy” rating to a “hold” rating in a research report on Tuesday, October 1st. Evercore ISI lowered their target price on Baxter International from $46.00 to $45.00 and set an “outperform” rating on the stock in a report on Tuesday, July 2nd. Morgan Stanley cut Baxter International from an “equal weight” rating to an “underweight” rating and reduced their price objective for the company from $39.00 to $30.00 in a research report on Monday, July 15th. Finally, Wells Fargo & Company dropped their target price on shares of Baxter International from $44.00 to $40.00 and set an “equal weight” rating on the stock in a research report on Wednesday, August 7th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, Baxter International presently has an average rating of “Hold” and an average price target of $42.00.

Baxter International Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.